Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


What makes a drug discovery consortium successful?

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 19, 737-738 (2020)



  1. Reichman, M. & Simpson, P. B. Open innovation in early drug discovery: roadmaps and roadblocks. Drug Discov. Today 21, 779–88 (2016).

    PubMed  Article  Google Scholar 

  2. Bryans, J. S., Kettleborough, C. A. & Solari, R. Are academic drug discovery efforts receiving more recognition with declining industry efficiency? Expert Opin. Drug Discov. 14, 605–607 (2019).

    PubMed  Article  Google Scholar 

  3. Tralau-Stewart, C. J. et al. Drug discovery: new models for industry-academic partnerships. Drug Discov. Today 14, 105–101 (2009).

    PubMed  Article  Google Scholar 

  4. Papadaki, M. & Hirsch, G. Curing consortium fatigue. Sci. Transl Med. 5, 200sf35 (2013).

    PubMed  Article  Google Scholar 

Download references

Competing Interests

The authors declare no competing interests.

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links